Výsledky vyhledávání - "Myelodysplastic Syndromes/classification/drug therapy/*therapy"

Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes

Autor: Tsiara, S. N., ELENI KAPSALI, Panteli, K., Christou, L., Bourantas, K. L.

Publikováno v: Scopus-Elsevier

Amifostine is a cytoprotective agent mainly used in cancer therapies, in order to ameliorate the toxic effects of anticancer chemotherapy and radiotherapy. In the past years an intriguing number of applications of amifostine have been identified; one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dfe2b38b03a55c9ac99ce9c78f788211
http://olympias.lib.uoi.gr/jspui/handle/123456789/19136

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání